This is a well-established cellular therapy used to treat various blood cancers (leukemias, lymphomas, myelomas) and some non-malignant blood disorders (aplastic anemia, thalassemia, sickle cell disease). It involves replacing

This innovative immunotherapy involves collecting a patient's T-cells, genetically engineering them to express a chimeric antigen receptor (CAR) that targets specific proteins on cancer cells, and then infusing

This field is rapidly evolving, and may include therapies involving natural killer (NK) cells, tumor-infiltrating lymphocytes (TILs), and other modified immune cells to target hematological malignancies.

Using drugs that specifically target molecules involved in cancer cell growth and survival, often with fewer side effects than chemotherapy. Examples include tyrosine kinase inhibitors for CML and drugs

Managing side effects of cancer treatments, preventing infections, providing nutritional support, and addressing psychological and emotional needs.

Replacing diseased bone marrow with healthy stem cells.

Autologous, Allogeneic, Haploidentical

Focusing on improving the quality of life for patients with advanced cancer and managing symptoms.

Harnessing the body's own immune system to fight cancer.

Monoclonal antibodies, Checkpoint inhibitors, Interferons and interleukins, CAR T-cell therapy

Using drugs to kill cancer cells or stop their growth. This can be given orally, intravenously, or intrathecally (into the spinal fluid).

Management of symptoms and complications related to blood disorders.

To replace deficient blood components like red blood cells (for anemia), platelets (for bleeding), or plasma (for clotting disorders).

An allogeneic bone marrow transplant (BMT) is a procedure in which a patient receives healthy stem cells from a compatible donor to replace damaged or diseased bone marrow....